Survival of secondary recipients
. | . | Secondary recipients . | . | . | ||
---|---|---|---|---|---|---|
Primary mouse . | Tx dose, cells . | WBC, × 106 cells/mL . | RBC, × 1010 cells/mL . | Survival, d . | ||
Experiment 2 | ||||||
GFP CTL | 1 × 106 | 6.85 ± 1.2 | 1.4 ± 0.04 | > 180 | ||
NUP98-TOP1 | 1 × 106 | 402 ± 9.0 | 0.47 ± 0.16 | 46.3 ± 7.5 | ||
1 × 105 | 286 ± 45 | 0.51 ± 0.30 | 60 ± 13.9 | |||
1 × 104 | 156 ± 54 | 0.79 ± 0.44 | 76.3 ± 1.5 | |||
1 × 103 | 60.6 ± 54 | 0.11 ± 0.02 | 105.3 ± 58.7 | |||
Experiment 3 | ||||||
GFP CTL | 1 × 106 | 9.8 ± 0.87 | 1.2 ± 0.05 | > 180 | ||
NUP98-TOP1 | 1 × 103 | 14.5 ± 2.1 | 0.77 ± 0.30 | 76.3 ± 11 | ||
1 × 102 | 19.8 ± 7.0 | 0.92 ± 0.26 | 79.7 ± 12 | |||
Experiment 9 | ||||||
NUP98-TOP1 | 1 × 103 | 15.7 × 0.60 | 1.2 ± 0.10 | 126.7 ± 24 | ||
NT-Y723F | 1 × 103 | 20.3 ± 7.8 | 0.98 ± 0.42 | 145.2 ± 5.3 |
. | . | Secondary recipients . | . | . | ||
---|---|---|---|---|---|---|
Primary mouse . | Tx dose, cells . | WBC, × 106 cells/mL . | RBC, × 1010 cells/mL . | Survival, d . | ||
Experiment 2 | ||||||
GFP CTL | 1 × 106 | 6.85 ± 1.2 | 1.4 ± 0.04 | > 180 | ||
NUP98-TOP1 | 1 × 106 | 402 ± 9.0 | 0.47 ± 0.16 | 46.3 ± 7.5 | ||
1 × 105 | 286 ± 45 | 0.51 ± 0.30 | 60 ± 13.9 | |||
1 × 104 | 156 ± 54 | 0.79 ± 0.44 | 76.3 ± 1.5 | |||
1 × 103 | 60.6 ± 54 | 0.11 ± 0.02 | 105.3 ± 58.7 | |||
Experiment 3 | ||||||
GFP CTL | 1 × 106 | 9.8 ± 0.87 | 1.2 ± 0.05 | > 180 | ||
NUP98-TOP1 | 1 × 103 | 14.5 ± 2.1 | 0.77 ± 0.30 | 76.3 ± 11 | ||
1 × 102 | 19.8 ± 7.0 | 0.92 ± 0.26 | 79.7 ± 12 | |||
Experiment 9 | ||||||
NUP98-TOP1 | 1 × 103 | 15.7 × 0.60 | 1.2 ± 0.10 | 126.7 ± 24 | ||
NT-Y723F | 1 × 103 | 20.3 ± 7.8 | 0.98 ± 0.42 | 145.2 ± 5.3 |
Values are mean ± SD. For experiment 2, WBC and RBC values were taken at 4 weeks after transplantation (tx). For experiments 3 and 9, WBC and RBC values were taken at 8 weeks after tx.